Taiwan Liposome Company, Ltd. (TLC) and trades at $7.00. The 52-week range is 7-7.09.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-24.89, annual revenue of $101.93M.
The stock has a beta of 0.80, operates in the Healthcare sector.
